Why Spectrum Pharmaceuticals Is Climbing
Spectrum Pharmaceuticals saw its shares make a handy gain early on Tuesday after the firm provided an update on its midstage non-small cell lung cancer study.
All Work
Chris Lange
Monday’s Biggest Winners and Losers in the S&P 500
Monday was another positive day for the broad U.S. markets. This was yet another push towards recovery and back to even for the three major indices. Crude oil also made a handy recovery as…
What to Expect From the 3 Major Banks Reporting This Week
The biggest companies posting quarterly results this week are banks, which always kick off the new earnings season.
Surface Oncology Announces Potential Pricing for IPO
Surface Oncology intends to price 6 million shares to result in an initial public offering valued up to more than $103 million.
Therapix Takes a Big Step Forward With Its Cannabinoid Platform
Therapix Biosciences shares made a solid gain to start the week after it announced topline results for its cannabinoid product platform.
Merck Moves Ahead With Late-Stage Trial Win
Shares of Merck had a boost early Monday after the firm announced that its Phase 3 trial of Keytruda for the treatment of metastatic non-small cell lung cancer met its primary endpoint.
Why Menlo Therapeutics Shares Were Halved
Menlo Therapeutics shares were slaughtered early on Monday after the firm issued an update for its midstage clinical trial for patients with atopic dermatitis.
JPMorgan, Citigroup, Wells Fargo and More Companies Reporting This Week
24/7 Wall St. has put together a preview of Citigroup, Rite Aid, Wells Fargo and some of the other top companies reporting their latest results in the coming week.
What Analysts Are Saying After NetApp’s Buyback and Dividend Hikes
NetApp held its analyst day this past week, and the firm announced a sizable share repurchase plan and hiked its dividend. Analysts praised these moves and hiked their targets in response.
Carnival Adds Even More Cruises to Cuba in the Coming Years
Back in 2017, Cuba was officially opened up to the U.S. for tourists and trade. And now cruise operators like Carnival are taking advantage of these open ports and tourist attractions.
Goosehead Gears Up for IPO
Goosehead Insurance has filed with the SEC regarding its initial public offering.
Urban Outfitters Makes a Change at the Top
Urban Outfitters shares dipped on Friday after the retailer announced that there would be a change in its executive leadership.
What Has Tanked Incyte and NewLink Genetics
Incyte saw its shares make a sharp left turn on Friday after the firm gave an update on its late-stage collaboration with Merck. NewLink Genetics felt the sting as well.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was another consecutive positive day for the broad U.S. markets. This was yet another push towards recovery and back to even for the three major indices. Crude oil also made a handy recover…
How Veritone Is Breaking Through With Its AI Platform
Veritone watched its shares climb on Thursday after the company announced that it would be launching a market-first update to its aiWARE operating system.
Google Accomplishes Incredible Renewable Energy Feat
Google just made a huge step forward in terms of its renewable energy mission, but given its growth, can it keep up?
Meet Vrio’s Big, Bold IPO
AT&T spin-off Vrio expects to price more than 29 million shares in a range that results in an initial public offering valued up to about $751 million.
LinkedIn Sees Even More Job Growth in March
This LinkedIn report comes out on a monthly basis and highlights who is hiring in the United States and where jobs are growing the quickest.
Conatus Pharmaceuticals Stumbles on Midstage Miss
Conatus Pharmaceuticals shares took a big step back on Thursday after the firm announced that its midstage proof-of-concept clinical trial in liver transplant patients with fibrosis or cirrhosis failed to live up to expectations.
Is Conn’s in Trouble After Q4 Earnings?
Conn’s released mixed fiscal fourth-quarter financial results before the markets opened on Thursday.